Anti-Dyskinesia Agents
DBCAT000129Pharmacologic class
Drugs used in the treatment of movement disorders. Most of these act centrally on dopaminergic or cholinergic systems. A DrugBank category of 36 drugs. 24 of them are approved.
- Also known as
- Agents, Anti-Dyskinesia · Agents, Movement Disorder · Anti Dyskinesia Agents · Antidyskinetics · Disorder Agents, Movement
What you can answer from here — as of August 24, 2016
Which targets do Anti-Dyskinesia Agents share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account